Company:  KYTHERA BIOPHARMACEUTICAL ... (KYTH)
Form Type:  8-K
Filing Date:  9/9/2013 
CIK:  0001436304 
Address:  27200 WEST AGOURA ROAD
SUITE 200
 
City, State, Zip:  CALABASAS, California 91301 
Telephone:  818-587-4500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$34.14  
Change: 
-1.64 (-4.58%)  
Trade Time: 
Apr 24  
Market Cap: 
$773.51M
Description of Business
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. Our objective is to develop first-in-class, prescription products using an approach that relies on the scientific rigor of biotechnology to address unmet needs in the rapidly-growing market for aesthetic medicine. Our initial focus is on the facial aesthetics market, which comprises the majority of the aesthetic medicine market. Our product candidate, ATX-101, is a potential first-in-class, injectable drug in late-stage clinical development for the reduction of submental fat, which commonly presents as an undesirable "double chin." Based on clinical trials conducted to date, ATX-101 has exhibited significant, meaningful and long-lasting results in the reduction of submental fat.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 8 OTHER EVENTS
      Item 8.01 Other Events.
    SIGNATURES
BROKERAGE PARTNERS